Bristol-Myers Squibb | BMY - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 364.22B 20.46B 2026-05
Abbott USD 178.41B 39.46B 2026-03
ALKERMES USD 5.66B 217M 2026-05
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 232.75B 75B 2026-05
Novo Nordisk A/S DKK 1.45T 421.31B 2026-05
Perrigo USD 1.58B 265M 2026-05
Pfizer USD 147.4B 6.42B 2026-05
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.57B 233M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
United Therapeutics USD 28.08B 2.9B 2026-05
Zoetis USD 39.98B 9.73B 2026-05